Massachusetts General Hospital
Circulating tumor cells can reveal genetic signature of dangerous lung cancers
Published in Blood Weekly, July 17th, 2008
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
"The CTC-chip opens up a whole new field of studying tumors in real time," says Daniel Haber, MD, director of the MGH Cancer Center and the study's senior author. "When the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-07-17)
More Articles from Blood Weekly
- Boston University
Disclosing violence to primary care or obestetrics/gynecology physicians most beneficial - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center LA BioMed
New study finds coronary arterial calcium scans help detect overall death risk in the elderly - University of Illinois at Chicago
UIC researchers make promising finding in severe lung disease - UT Southwestern Medical Center
Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence - Virginia Tech
Review article provides tools for the Rosaceae genomics community - Whitehead Institute for Biomedical Research
New technique produces genetically identical stem cells - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
